Observing IBD patients with fatty liver disease
Official title: A Bidirectional, Multicenter Cohort Study of Inflammatory Bowel Disease (IBD) Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Run by Shanghai East Hospital · NCT06939569 · Data updated 2026-11-12
This study looks at people with inflammatory bowel disease to see how common fatty liver disease is among them and how it affects their overall health.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 337 (estimated) |
| Sponsor | Shanghai East Hospital Academic / other |
| Locations | 1 site (Shanghai) |
| Status | Recruiting |
| Started | May 1, 2025 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | April 23, 2025 |
| Trial ID | NCT06939569 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults over 18 years old diagnosed with inflammatory bowel disease.
✕Probably not a fit
Patients with incomplete clinical data or severe comorbidities may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study focuses on patients with inflammatory bowel disease (IBD) and examines the prevalence and impact of non-alcoholic fatty liver disease (NAFLD) among them. It aims to identify the similarities and differences between IBD patients with and without NAFLD, as well as to assess how the presence and severity of NAFLD may influence the clinical outcomes of IBD. The study will utilize a cohort of previously established IBD patients to gather relevant clinical data and insights.
Why it matters
Potential benefit: If successful, this study could enhance understanding of the relationship between IBD and NAFLD, leading to improved management strategies for affected patients.
How similar studies have gone: There have been no relevant studies to date that specifically address the relationship between IBD and NAFLD, making this approach novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Subjects aged over 18 years (including borderline values), of either sex. 2. Subjects consistented with the Chinese consensus on the diagnosis and treatment of IBD; 3. Subjects able to cooperate with follow-up, participate in this study and sign the informed consent. Exclusion Criteria: 1. Subjects with incomplete clinical data; 2. Subjects can not to cooperate with follow-up, and refuse to sign the informed consent; 3. Subjects can not to cooperate with the completion of relevant examinations; 4 Pregnant women; 5.Subjects with severe heart, lung, kidney and other organ diseases or cancer, and expected survival time less than 6 months.
Where it's running
-
Shanghai East Hospital
Shanghai, China Recruiting
Study contacts
- Study coordinator: Lan Zhong, MD
- Email: lanzhong@tongji.edu.cn
- Phone: 8613162099450
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
DISC-0974-201 for adults with IBD-related anemia
This Phase 2 trial will test whether DISC-0974-201 helps adults with inflammatory bowel disease who have anemia driven by inflammation.
-
Moderate breathing and movement: Can regular exercise help people with quiescent inflammatory bowel disease feel better?
This trial tests whether a moderate-intensity exercise program improves quality of life for adults with Crohn's disease or ulcerative colitis who are currently in clinical remission.
-
Mediterranean Diet and Time-Restricted Feeding in Ulcerative Colitis in Remission
This study tests whether a Mediterranean diet, with or without an 8-hour eating window, helps gut health and quality of life in adults with ulcerative colitis in remission.
-
Screening for lipid disorders in children and teens with chronic diseases to flag cardiovascular risk
This study tests a blood test and a questionnaire to screen children and teens with chronic conditions for lipid metabolism disorders and familial hyperlipidemia.
-
Wearable data to spot IBD flareups in people with ulcerative colitis or Crohn's disease
This study tests whether heart‑rate variability from participants’ own wearables can help predict IBD flares.
-
Liver Inflammation Index test for MASH in adults with T2DM and MAFLD
This study tests a Liver Inflammation Index to see if it can identify MASH in adults who have both type 2 diabetes and MAFLD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.